James Deline, MD
Surgery · Denver, CONPI 1679679229
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (43.9%), travel and lodging and education — rather than concentrated in one kind of arrangement. 19 manufacturers reported payments, led by TELA Bio, Inc. at 57.8% of the total. Reporting peaked in 2024 at $10,674 and has fallen 84.9% since, to $1,607 in 2025.
Across 164 payments — averaging $131.07 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- TELA Bio, Inc.$12K
- Intuitive Surgical$8K
- Davol Inc.$542
- Medtronic$56
- Conmed Corporation$33
- Innovation Technologies Inc$30
- plus $249 from 13 others
Across 1 payment — averaging $6758.70 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- TELA Bio, Inc.$7K
What the payments were for
- Consulting fees$5002%
- Speaking & faculty fees$2,0009%
- Travel & lodging$5,50326%
- Food & beverage$9,44444%
- Education$4,03519%
- Gifts$140%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| TELA Bio, Inc. | 112 | $12,422 |
| Intuitive Surgical | 28 | $8,164 |
| Davol Inc. | 8 | $542 |
| Medtronic | 1 | $56 |
| Conmed Corporation | 1 | $33 |
| Innovation Technologies Inc | 1 | $30 |
| Johnson & Johnson | 1 | $26 |
| BD | 1 | $26 |
| AbbVie | 1 | $23 |
| Innocoll Pharmaceuticals Limited | 1 | $22 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $21 |
| Aroa Biosurgery Incorporated | 1 | $21 |
| Acell, Inc. | 1 | $20 |
| Teleflex LLC | 1 | $20 |
| Merck | 1 | $18 |
| Covidien LP | 1 | $15 |
| Mallinckrodt Hospital Products Inc. | 1 | $13 |
| Optinose US, Inc. | 1 | $12 |
| Boston Scientific | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$21,496 in reported general payments places this provider in the 85th percentile of 469 surgery providers in Colorado.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Oxycodone Hcl | 22 | $58 |
Paid to pharmacies, not to this prescriber.
Other surgery in Denver
- Anthony CanfieldDenver$854K
- Michael SnyderDenver$123K
- Edward JonesDenver$70K
- Drew AlbrightDenver$46K
- Jeffrey CrossDenver$40K
- John WeaverDenver$39K
- Megan LooDenver$36K
- Scott GolembeskiDenver$30K
- David BaerDenver$26K
- Kimberly VanderveenDenver$24K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.